Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Pfizer or Roche as jv partners for the NMIBC

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Jan 25, 2023 5:29am

151 Views

Post# 35244381

RE:RE:RE:RE:Pfizer or Roche as jv partners for the NMIBC

CanerSlayer, thats why this makes perfect sense for Pfizer or Roche to JV with us ASAP to keep Merck away, this would allow us to get heavily into our second and third indications with money on hand and then get the big buyout, this move may move us up to the nasdaq once we qualify for that with better and sustained share price, i still believe we will have BTD and AA in hand probably in month or 2 latest. Bottom line is Roger is not selling this cheap after all these years

<< Previous

Bullboard Posts

Next >>

Infield Minerals to acquire Kings Canyon Gold Property